-
-
-
-
-
-
-
AbbVie Reports Second-Quarter 2026 Financial Results
-
-
-
-
-
-
-
AbbVie sharpens immunology focus with $10.9 billion Apogee deal
-
-
-
-
-
-
-
AbbVie plans $380 million manufacturing expansion in North Chicago
-
-
-
-
-
-
-
Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy
-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Abbvie (ABBV)
-
-
-
-
-
-
-
AbbVie earnings preview Q2: set for flat quarter with guidance, M&A in focus
-
-
-
-
-
-
-
AbbVie cuts 2025 profit forecast on acquisition expenses
-
1,188,201 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

